Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- CHUMAKOV M. P., DZAGUROV S. G., LASHKEVICH V. A., GRACHEV V. P., MIRONOVA L. L., RALF N. M., ELBERT L. B. METODY I REZUL'TATY IZGOTOVLENIIA ZHIVO I POLIOMIELITNO I VAKTSINY, NE SODERZHASHCHE I PRIMESE I VAKUOLIZIRUIUSHCHEGO VIRUSA (OB40-SV40) Vopr Virusol. 1963 Jul-Aug;29:445–449. [PubMed] [Google Scholar]
- Janda Z., Adam E., Vonka V. Properties of a new type 3 attenuated poliovirus. VI. Alimentary tract resistance in children fed previously with type 3 Sabin vaccine to reinfection with homologous and heterologous type 3 attenuated poliovirus. Arch Gesamte Virusforsch. 1967;20(1):87–98. [PubMed] [Google Scholar]
- SIMON J. PROPERTIES OF A NEW ATTENUATED TYPE 3 POLIOVIRUS. II. NEUROVIRULENCE TESTS ON MONKEYS. Arch Gesamte Virusforsch. 1965;15:220–233. [PubMed] [Google Scholar]
- Simon J., Vonka V., Janda Z. Properties of a new type 3 attenuated poliovirus. V. Neurovirulence tests in monkeys after a passage through the human alimentary tract. Arch Gesamte Virusforsch. 1965;15(5):681–689. [PubMed] [Google Scholar]
- Unterharnscheidt F., Simon J. Die Neurovirulenz eines neuen attenuierten Poliovirus Typ 3 (USOL-D) im Affenversuch. Naturwissenschaften. 1965 Sep;52(17):502–502. doi: 10.1007/BF00646594. [DOI] [PubMed] [Google Scholar]
- VONKA V., JANDA Z., SIMON J., ADAM E., ZAVADOVA H., STAREK M. PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. 3. A SMALL SCALE TRIAL WITH USOL-D BAC VIRUS IN A CLOSED CHILD COMMUNITY. Arch Gesamte Virusforsch. 1965;15:234–243. [PubMed] [Google Scholar]
- VONKA V., JANDA Z., SIMON J. THE PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. I. DERIVATION OF NEW TYPE 3 ATTENUATED POLIOVIRUSES AND THEIR LABORATORY CHARACTERISTICS. Arch Gesamte Virusforsch. 1964 Jun 17;14:599–610. doi: 10.1007/BF01555117. [DOI] [PubMed] [Google Scholar]
- Vonka V., Janda Z., Simon J., Adam E., Stárek M. A new type 3 attenuated poliovirus for possible use in oral poliovirus vaccine. Prog Med Virol. 1967;9:204–255. [PubMed] [Google Scholar]
